To evaluate the epidemiology of insomnia, including demographic and clinical correlates, in older adults. DESIGN: Cross-sectional. SETTING: Community. PARTICIPANTS: Yale Precipitating Events Project participants (N5379; mean age 84.3; 67.8% female; 11.9% African American). MEASUREMENTS: Insomnia Severity Index (ISI), with scores of 8 and higher indicating insomnia, which was further stratified according to ISI score as mild (8) (9) (10) (11) (12) (13) (14) , moderate (15-21), or severe (22-28). Baseline characteristics included age, sex, race, education, smoking, obesity, medical conditions, depressive symptoms (Center for Epidemiologic Studies Depression score 16), cognitive impairment (Mini-Mental State Examination score <24), restless legs syndrome (RLS), self-reported sleep-disordered breathing (SDB), medications, and daytime sleepiness (Epworth Sleepiness Scale (ESS), range 0-24). RESULTS: Insomnia was established in 163 (43.0%) participants (average ISI score 12.3 (mild)). For the entire sample, average baseline characteristics were as follows: 30.1% did not complete high school, 5% were current smokers, 19.2% were obese, 28.2% had cardiovascular disease, 19.3% had chronic lung disease, 27.2% had depressive symptoms, 16.1% had cognitive impairment, 36.8% had RLS, and 3.4% had self-reported SDB; mean number of medications was 9.2, and mean ESS was 6.4. In multivariable regression models, only depressive symptoms (adjusted odds ratio (aOR)58.34, 95% confidence interval (CI)54.49, 15.47) and RLS (aOR52.49, 95% CI51.48, 4.21) were significantly associated with insomnia. CONCLUSION: In a sample of older adults with high medical burden and polypharmacy, insomnia was highly prevalent but unexpectedly mild and associated only with depressive symptoms and RLS. The discordance of high prevalence but mild severity of insomnia in the oldest adults highlights the need for diagnostic confirmation with objective measures of sleep disturbances, whereas the strong associations with depressive symptoms and RLS inform priorities in managing insomnia. J Am Geriatr Soc 2018.
A lthough prior work has shown that insomnia commonly occurs in older persons, [1] [2] [3] [4] [5] the oldest adults (80) have been underrepresented. There was also heterogeneity in the methods used to evaluate insomnia, with some studies including single-item sleep questions, 3, 4 which do not distinguish between insomnia symptoms and insomnia diagnosis (defined as insomnia symptoms with a negative effect on daytime functioning). 2, 6, 7 In contrast, the Insomnia Severity Index (ISI) is a validated screening questionnaire that captures self-reported insomnia symptoms and daytime impairments and is thus useful for identifying insomnia and its severity in epidemiological studies. 6, 7 We evaluated the epidemiology of insomnia and its severity, measured using the ISI, in a sample of communityliving persons with a mean age of 84.3 (range 78-102) years. We hypothesized that insomnia would be more prevalent and severe with advancing age and cross-sectionally associated with certain demographic and clinical characteristics.
METHODS

Study Population
Participants were drawn from the Yale Precipitating Events Project, an ongoing longitudinal study of community-living persons. 8 Collection of information on the ISI began 7 years after the study was initiated (at the 90-month interview in 2005-07 [N5379, 50.3% of initial cohort]). Supplementary Appendix S1 provides detailed information on the Precipitating Events Project cohort and describes differences between our analytical sample and the initial cohort. The Yale University Human Investigation Committee approved the study protocol, and all participants provided written informed consent.
Demographic and Clinical Characteristics
Characteristics included age, sex, race, education, smoking status, body mass index, cardiovascular disease (selfreported, physician-diagnosed myocardial infarction, stroke or congestive heart failure), chronic lung disease (self-reported, physician-diagnosed chronic obstructive pulmonary disease, bronchitis, emphysema, or asthma), depressive symptoms (Center for Epidemiologic Studies Depression Scale score 16), 9 cognitive impairment (MiniMental State Examination score <24), 10 and medication use (prescribed and over the counter).
Sleep-related conditions included primary sleep disorders (restless legs syndrome (RLS), sleep-disordered breathing (SDB)) and daytime sleepiness. RLS and SDB were assessed according to self-report. To ascertain whether participants had RLS, they were asked, 11 "At night, while lying in bed, do you feel that various parts of your body are restless, and do you also have an urge to move, especially your legs or feet, that may decrease if you move or rub your legs or feet?" Those who reported experiencing this sensation at least once per week over the previous 2 weeks were considered to have RLS. SDB was defined as self-reported, physician diagnosed sleep apnea or presence of a breathing disorder that happens only during sleep. Daytime sleepiness was assessed using the Epworth Sleepiness Scale (ESS), with scores ranging from 0 to 24 and with a score of 10 or higher previously validated as establishing excessive daytime sleepiness in older adults.
12,13
Insomnia Severity Index
The ISI consists of 7 questionnaire items that capture selfreported symptoms and daytime consequences of insomnia, according to criteria from the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition.
6,7 ISI scores range from 0 to 28, with higher scores indicating more severe insomnia.
6,7 ISI scores of 8 or higher indicated insomnia, with severity further stratified according to ISI score as subthreshold (herein termed mild) (8) (9) (10) (11) (12) (13) (14) , moderate (15) (16) (17) (18) (19) (20) (21) , and severe (22) (23) (24) (25) (26) (27) (28) . 6, 7 Supplementary Appendix S1 summarizes prior work that has validated the ISI as a screening questionnaire for identifying insomnia in epidemiological studies. 6, 7 
Statistical Analysis
Distributions of clinical characteristics were summarized as means 6standard deviations) or frequencies (%), and compared between participants with and without insomnia (ISI 8) using the Student t-test or chi-square-test, as appropriate.
In unadjusted logistic regression models, we examined separately the association between each demographic and clinical characteristic and the outcome of insomnia (ISI8). We then simultaneously included all characteristics in an adjusted logistic regression model to estimate the independent association between each characteristic and insomnia using adjusted odds ratios (ORs) and 95% confidence intervals (CIs). In linear regression models, we examined the association between demographic and clinical characteristics and insomnia severity (ISI score) as the outcome. These linear regression models were used to estimate unadjusted and adjusted absolute differences and their 95% CIs in predicted ISI scores associated with each characteristic.
ESS data were missing for 5.5% of participants, and data on RLS, self-reported SDB, and number of medications were missing for fewer than 5% of participants. Complete data were available for all other variables in the analysis. We used missing category for ESS as an alternative to complete-case analyses in the logistic regression model, but this did not change our results substantially. We therefore present only the complete-case analyses.
All analyses were conducted using SAS version 9.4 (SAS Institute, Inc., Cary, NC). Model fit was inspected using collinearity diagnostics and residual plots (with no problems identified). P<.05 was taken to indicate statistical significance. Table 1 reports demographic and clinical characteristics. Mean participant age was 84.3, 67.8% were female, 11.9% were African American, 30.1% did not complete high school, 5% were current smokers, and 19.2% were obese (body mass index 30.0 kg/m 2 ). The prevalence of other characteristics confirmed high medical burden and polypharmacy. Participants with insomnia (ISI8) had a higher prevalence of depressive symptoms and RLS, took more medications, and had higher ISI and ESS scores than those without. Mean ISI was 12.3 in those with insomnia and 3.0 in those without.
RESULTS
In the multivariable model, only depressive symptoms (aOR58.34, 95% CI54.49-15.47) and RLS (aOR52.49, 95% CI51.48-4.21) were strongly associated with insomnia ( Table 2) . Table 3 reports the associations between certain characteristics and severity of insomnia symptoms as measured according to predicted absolute difference in ISI score (continuous variable). In the multivariable model, participants with depressive symptoms had ISI scores that were 5.14 (95% CI53.97-6.32) points higher than those without, and participants with RLS had ISI scores that were 2.20 (95% CI51.12-3.27) points higher than those without.
DISCUSSION
We evaluated the epidemiology of insomnia (ISI8) and its severity (ISI range 0-28) in a sample of 379 community-living older persons with a mean age of 84.3, high medical burden, and polypharmacy. Our results show that insomnia was highly prevalent (43.0%) but unexpectedly mild in severity (mean ISI 12.3) and associated only with depressive symptoms and RLS.
Older persons are at high risk of insomnia, with aging adversely affecting sleep-wake physiology and being associated with high medical burden and polypharmacy. [1] [2] [3] [4] [5] Self-reported, physician-diagnosed myocardial infarction, stroke, or congestive heart failure. Thus, our observation that insomnia is highly prevalent in older persons with high medical burden and polypharmacy but mild in severity is surprisingly discordant. There are several possible mechanisms for this discordance. First, insomnia may be better tolerated in older age because of lower daily demands (sedentary, retired) and greater flexibility in sleep-wake scheduling. 14, 15 Second, the paradox of well-being, in which older persons are less likely to report dissatisfaction because their actual state of health exceeds the expected level, may lead to underreporting of insomnia severity. 16 Finally, prior work has shown an association between aging and reductions in sensory awareness of symptom severity; for example, older persons report milder respiratory symptoms in response to bronchoconstriction and have decreased symptoms in response to hypoglycemia and higher rates of silent myocardial ischemia than younger persons. [17] [18] [19] A recent study also found milder levels of insomnia and daytime sleepiness in older than middle-aged persons, despite more severe polysomnography-confirmed primary sleep disorders in older age. 20 Nonetheless, our results highlight 2 conditions, depressive symptoms and RLS, as having strong associations with insomnia. Although we cannot infer causation in this cross-sectional analysis, prior work has established a strong basis for these as causal factors in insomnia. 21, 22 Our results, therefore, confirm that RLS and depressive symptoms may be modifiable targets in older adults with insomnia. These conditions may be treated with behavioral therapies (e.g. avoidance of alcohol and caffeine in RLS) [23] [24] [25] and cognitive behavioral therapy (for depression). 26 Behavioral interventions are especially meaningful in older adults, given their vulnerability to adverse effects from polypharmacy. 27 Moreover, because depressive symptoms were prevalent in our study sample, behavioral interventions that target depression and insomnia may be increasingly required in advanced age.
RLS may occur in response to nutritional deficiencies (iron, folate, magnesium), uremia, and medications (antidepressants, sedating antihistamines, central dopamine receptor antagonists). 25 Given these secondary mechanisms, we posit that the high prevalence of RLS in our study sample (36.8%) may have been due to a high medical burden and polypharmacy.
We did not find an association between age and insomnia over our age range of 78 to 102. The association between age and insomnia symptoms has been examined in many studies, with mixed results. 5 When specifically examining the association between age and insomnia, 5, 28 it has been suggested, as was found in our study, that insomnia does not increase in prevalence in elderly individuals. Another study found lower rates of insomnia in persons aged 65 and older.
14 It is possible that older persons with insomnia symptoms are less likely to report a negative effect on daytime functioning, which is required to fulfill a diagnosis of insomnia. 5, 14 Another explanation is that most age-related changes in sleep-wake physiology have taken place by the seventh decade of life, 29 suggesting that aging alone would have a minimal effect on perceived sleep quality in our sample of older persons with an average age of 84.3.
We found that cardiorespiratory conditions, cognitive impairment, self-reported SDB, and polypharmacy were not significantly associated with insomnia, despite evidence that these characteristics are risk factors for insomnia in younger individuals. [1] [2] [3] [4] [5] As to mechanisms underlying this lack of association, we again postulate that advanced age may be increasingly associated with the paradox of well-being, reduced sensory awareness to symptom severity, and lower daily demands that allow older persons to better tolerate less restorative sleep do not require. [14] [15] [16] In contrast, the strong associations between depressive symptoms and RLS and insomnia in our study sample may reflect shared diagnostic features of these conditions. (These diagnoses are symptom based, in contrast to criteria that establish cardiorespiratory disease (spirometry, echocardiography).)
The strengths of this study include use of a validated screening instrument to assess insomnia in participants with advanced age, and concurrent availability of many demographic and clinical characteristics. There are also potential limitations. First, our modest sample size may have limited the statistical power of our analyses. Second, participants were drawn from a single urban area, limiting the generalizability of our results. Third, SDB was assessed according to self-report rather than polysomnography, which underestimated the prevalence of this condition and its association with insomnia. 30 Third, the severity of available medical conditions could not be established objectively, and other risk factors for having insomnia were not evaluated, including anxiety, digestive disease, sleep-disruptive symptoms (e.g., nocturia, dyspnea, pain), and psychosocial factors. Finally, the effect of medications (e.g., hypnotics) as potentially attenuating an individual's perception of insomnia severity was not evaluated.
To address the noted limitations, future work should evaluate larger cohorts of the oldest adults and include a longitudinal design with a broader array of insomnia-based risk factors. Future work should also evaluate objective measures of sleep disturbances (e.g., actigraphy) to better ascertain the potential discordance of high prevalence but mild severity of self-reported insomnia in advanced age.
In conclusion, in our sample of community-living persons with advanced age, high medical burden and polypharmacy, we found that insomnia was highly prevalent but unexpectedly mild in severity and associated only with depressive symptoms and RLS. In advanced age, the discordance of high prevalence but mild severity of insomnia further highlights the need for diagnostic confirmation with objective measures of sleep disturbances while strong associations with depressive symptoms and RLS inform priorities in the management of insomnia.
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